Ionis Pharmaceuticals (NASDAQ:IONS) Stock Price Expected to Rise, JPMorgan Chase & Co. Analyst Says
Ionis Pharmaceuticals (NASDAQ:IONS – Free Report) had its price objective raised by JPMorgan Chase & Co. from $45.00 to $48.00 in a research note issued to investors on Thursday,Benzinga reports. The firm currently has a neutral rating on the stock. Several other analysts have also recently commented on IONS. BMO Capital Markets reduced their target […]
Ionis Pharmaceuticals (NASDAQ:IONS – Free Report) had its price objective raised by JPMorgan Chase & Co. from $45.00 to $48.00 in a research note issued to investors on Thursday,Benzinga reports. The firm currently has a neutral rating on the stock. Several other analysts have also recently commented on IONS. BMO Capital Markets reduced their target […]
